Ali Tafreshi
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.1%
- Immunology top 1%
- Cancer Research top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Andrew RobinsonDelvys Rodríguez‐AbreuSinéad CuffeRina HuiJulie R. BrahmerMaya GottfriedNir PeledKatsuyuki Hotta
- Topics
- Cancer Immunotherapy and Biomarkers (29 papers)Glaucoma and retinal disorders (19 papers)Lung Cancer Treatments and Mutations (16 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Ali Tafreshi
89 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 8.9k
- Pulmonary and Respiratory Medicine 6.2k
- Immunology 2.0k
- Cancer Research 1.3k
- Radiology, Nuclear Medicine and Imaging 1.2k
Countries citing papers authored by Ali Tafreshi
This map shows the geographic impact of Ali Tafreshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Tafreshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Tafreshi more than expected).
Fields of papers citing papers by Ali Tafreshi
This network shows the impact of papers produced by Ali Tafreshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Tafreshi. The network helps show where Ali Tafreshi may publish in the future.
Co-authorship network of co-authors of Ali Tafreshi
This figure shows the co-authorship network connecting the top 25 collaborators of Ali Tafreshi. A scholar is included among the top collaborators of Ali Tafreshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Tafreshi. Ali Tafreshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Studybreakdown → | 233 |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 20 | |
| 6 | 3 | |
| 7 | 12 | |
| 8 | 40 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 29 | |
| 12 | 2 | |
| 13 | 4 | |
| 14 | 10 | |
| 15 | 2 | |
| 16 | Repeatability Of Retinal And Anterior Segment Measurements With The Nidek Rs3000 Spectral Domain Oct | 1 |
| 17 | African Descent And Glaucoma Study (ADAGES): Comparison Of Rates Of Glaucomatous Progressive Nerve Fiber Layer Loss Between Patients Of European Descent And African-descent | 8 |
| 18 | 46 | |
| 19 | 98 | |
| 20 | 7 |
About Ali Tafreshi
Ali Tafreshi is a scholar working on Ophthalmology, Oncology and Pulmonary and Respiratory Medicine, having authored 92 papers that have together received 11.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (29 papers), Glaucoma and retinal disorders (19 papers) and Lung Cancer Treatments and Mutations (16 papers). The work is most often cited by research in Oncology (8.9k citations), Pulmonary and Respiratory Medicine (6.2k citations) and Ophthalmology (852 citations). Ali Tafreshi has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Andrew Robinson, Delvys Rodríguez‐Abreu, Sinéad Cuffe, Rina Hui, Julie R. Brahmer, Maya Gottfried, Nir Peled, Katsuyuki Hotta, Tibor Csőszi and Suman Rao. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.